Pharma-Bio Serv, Inc.

PBSV ·Industrials, Consulting Services, United States
Analysis › Moat Score

Moat Score — Pharma-Bio Serv, Inc.

Total Moat Score 3 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 0 / 5 The company explicitly states it owns no proprietary software and holds no notable patents or trademarks; its value is purely relational, not IP-based.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 0 / 5 As a small, fragmented-market consulting firm billing mostly time-and-materials, Pharma-Bio Serv has no structural cost advantage over regional or international competitors.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 0 / 5 Time-and-materials billing combined with client procurement and vendor-management pressure leaves the company with little ability to raise prices without losing work.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 Consulting services of this kind do not generate value that increases as more clients participate; each engagement stands largely on its own.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 2 / 5 Roughly 27 years of embedded relationships and familiarity with specific client facilities and regulatory histories create moderate switching friction, even though clients can terminate with little notice.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 1 / 5 A long-standing, concentrated presence within Puerto Rico's pharmaceutical manufacturing cluster gives Pharma-Bio Serv a modest local scale advantage, though low industry capital requirements limit how durable this is.